FI121273B - FAS/APO1-reseptorien toiminnan modulaattorit - Google Patents

FAS/APO1-reseptorien toiminnan modulaattorit Download PDF

Info

Publication number
FI121273B
FI121273B FI972457A FI972457A FI121273B FI 121273 B FI121273 B FI 121273B FI 972457 A FI972457 A FI 972457A FI 972457 A FI972457 A FI 972457A FI 121273 B FI121273 B FI 121273B
Authority
FI
Finland
Prior art keywords
protein
fas
mort
cells
sequence
Prior art date
Application number
FI972457A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972457A (fi
FI972457A0 (fi
Inventor
David Wallach
Mark Boldin
Eugene Varfolomeev
Igor Mett
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11200294A external-priority patent/IL112002A0/xx
Priority claimed from IL112692A external-priority patent/IL112692A/en
Priority claimed from IL11461595A external-priority patent/IL114615A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of FI972457A publication Critical patent/FI972457A/fi
Publication of FI972457A0 publication Critical patent/FI972457A0/fi
Application granted granted Critical
Publication of FI121273B publication Critical patent/FI121273B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transmitters (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Radar Systems Or Details Thereof (AREA)
FI972457A 1994-12-15 1997-06-10 FAS/APO1-reseptorien toiminnan modulaattorit FI121273B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
IL11200294A IL112002A0 (en) 1994-05-11 1994-12-15 Modulatiors of tnf/ngf superfamily receptors, their preparation and use
IL11200294 1994-12-15
IL11269295 1995-02-19
IL112692A IL112692A (en) 1995-02-19 1995-02-19 ANTIBODIES TO PROTEIN WHICH BINDS TO Fas-R
IL11461595 1995-07-16
IL11461595A IL114615A0 (en) 1995-07-16 1995-07-16 Modulators of the function of fas receptors and other proteins
PCT/US1995/016542 WO1996018641A1 (en) 1994-12-15 1995-12-14 Modulators of the function of fas/apo1 receptors
US9516542 1995-12-14

Publications (3)

Publication Number Publication Date
FI972457A FI972457A (fi) 1997-06-10
FI972457A0 FI972457A0 (fi) 1997-06-10
FI121273B true FI121273B (fi) 2010-09-15

Family

ID=27271687

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972457A FI121273B (fi) 1994-12-15 1997-06-10 FAS/APO1-reseptorien toiminnan modulaattorit

Country Status (18)

Country Link
EP (1) EP0871645B1 (no)
JP (1) JP3787355B2 (no)
KR (1) KR100536394B1 (no)
CN (1) CN1105725C (no)
AT (1) ATE377073T1 (no)
AU (1) AU706401B2 (no)
CA (1) CA2207815C (no)
CY (1) CY2586B2 (no)
DE (1) DE69535634T2 (no)
DK (1) DK0871645T3 (no)
ES (1) ES2292172T3 (no)
FI (1) FI121273B (no)
HK (1) HK1007248A1 (no)
MX (1) MX9704501A (no)
NO (1) NO324725B1 (no)
PT (1) PT871645E (no)
UA (1) UA58489C2 (no)
WO (1) WO1996018641A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) * 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
AU755662B2 (en) * 1995-02-22 2002-12-19 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
WO1996025941A1 (en) * 1995-02-22 1996-08-29 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US6399327B1 (en) 1995-07-16 2002-06-04 Yeda Research And Development Co. Ltd. Modulators of the function of FAS receptors and other proteins
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
EP0842665A3 (en) * 1996-11-14 2002-12-18 Smithkline Beecham Corporation Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
US5969102A (en) * 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
PT977846E (pt) * 1997-04-25 2002-11-29 Wyeth Corp Isoformas de morti neuronal
AU7988698A (en) * 1997-06-26 1999-01-19 Chiron Corporation Human fadd-interacting protein (fip)
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
US6015712A (en) * 1999-07-19 2000-01-18 Isis Pharmaceuticals Inc. Antisense modulation of FADD expression
ATE542545T1 (de) 2001-05-24 2012-02-15 Zymogenetics Inc Taci-immunoglobulin-fusionsproteine
US6743630B2 (en) 2002-03-06 2004-06-01 The Trustees Of Columbia University In The City Of New York Method of preparing a protein array based on biochemical protein-protein interaction
WO2007019573A2 (en) 2005-08-09 2007-02-15 Zymogenetics, Inc. Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules
EA016083B1 (ru) 2005-08-09 2012-02-28 Займоджинетикс, Инк. СПОСОБ ЛЕЧЕНИЯ НЕХОДЖКИНСКОЙ ЛИМФОМЫ С ПОМОЩЬЮ СЛИТОЙ МОЛЕКУЛЫ TACI-Ig
CN101489573B (zh) 2006-05-15 2013-05-22 阿雷斯贸易股份有限公司 用TACI-Ig融合分子治疗自身免疫疾病的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO178777C (no) * 1994-05-09 1996-05-29 Kvaerner Eng Varmeveksler
US7807783B1 (en) * 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US5674734A (en) * 1995-05-18 1997-10-07 President And Fellows Of Harvard College Cell death protein

Also Published As

Publication number Publication date
DK0871645T3 (da) 2007-12-03
HK1007248A1 (en) 1999-04-09
CA2207815A1 (en) 1996-06-20
NO972716L (no) 1997-07-11
ES2292172T3 (es) 2008-03-01
WO1996018641A1 (en) 1996-06-20
ATE377073T1 (de) 2007-11-15
CN1105725C (zh) 2003-04-16
EP0871645A4 (en) 1999-11-24
AU4602296A (en) 1996-07-03
PT871645E (pt) 2007-11-14
KR100536394B1 (ko) 2006-04-21
AU706401B2 (en) 1999-06-17
EP0871645B1 (en) 2007-10-31
UA58489C2 (uk) 2003-08-15
FI972457A (fi) 1997-06-10
CA2207815C (en) 2011-03-29
CN1169729A (zh) 1998-01-07
JPH10510712A (ja) 1998-10-20
DE69535634T2 (de) 2008-08-28
EP0871645A1 (en) 1998-10-21
FI972457A0 (fi) 1997-06-10
DE69535634D1 (de) 2007-12-13
NO972716D0 (no) 1997-06-12
CY2586B2 (en) 2009-11-04
JP3787355B2 (ja) 2006-06-21
MX9704501A (es) 1997-10-31
NO324725B1 (no) 2007-12-03

Similar Documents

Publication Publication Date Title
FI121273B (fi) FAS/APO1-reseptorien toiminnan modulaattorit
US8236507B2 (en) Modulators of TNF receptor associated factor (TRAF), their preparation and use
JP3980641B2 (ja) Ｆａｓ受容体およびほかのタンパク質の機能のモジュレーター
US20070166787A1 (en) Modulators of regulatory proteins
WO1996018641A9 (en) Modulators of the function of fas/apo1 receptors
EP0813419B1 (en) Modulators of regulatory proteins
IL109632A (en) Modulators of the function of tnf receptors
JP4351389B2 (ja) Ｔｎｆ／ｎｇｆレセプターファミリーおよびほかのタンパク質のレセプター機能調節物質
US7323548B2 (en) Modulators of the function of FAS/APO1 receptors
RU2241747C2 (ru) Молекула днк, кодирующая полипептид, способный связываться с внутриклеточным доменом рецептора лиганда fas(fas-ic), полипептид, способ его получения, вектор, способ модуляции действия лиганда fas-r на клетки (варианты), фармацевтическая композиция (варианты), спрособ выделения и идентификации белка
US7108999B1 (en) Modulators of the function of FAS/AP01 receptors
AU767967B2 (en) Modulators of TNF receptor associated factor (TRAF), their preparation and use
RU2235779C2 (ru) Последовательность днк, кодирующая полипептид, который связывается с mort-1 (варианты), полипептид (варианты) и способ его получения, вектор, способ модулирования действия лиганда fas-r или tnf на клетки (варианты), способ обработки клеток, способ выделения и идентификации белков, способ модулирования индуцируемого mort-1 действия или индуцируемого mort-1 связывающим белком действия на клетки
JP2009148285A (ja) Ｔｎｆ／ｎｇｆレセプターファミリーおよびほかのタンパク質のレセプター機能調節物質
IL112692A (en) ANTIBODIES TO PROTEIN WHICH BINDS TO Fas-R
IL126428A (en) Modulators of tnf receptor associated factor (traf), their preparation and use
AU5834599A (en) Modulators of regulatory proteins
CZ314699A3 (cs) Sekvence DNA, vektor a protein

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 121273

Country of ref document: FI

MA Patent expired